Polynucleotide phosphorylase and mitochondrial ATP synthase mediate reduction of arsenate to the more toxic arsenite by forming arsenylated analogues of ADP and ATP

Toxicological Sciences

Volumn 117, Issue 2, 2010, Pages 270-281

  Németi, Balázs ^a   Regonesi, Maria Elena ^b   Tortora, Paolo ^b   Gregus, Zoltán ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Arsenate; Arsenolysis; ATP synthase; Glutathione; Polynucleotide phosphorylase; Reduction

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ARSENIC ACID; ARSENIC TRIOXIDE; GLUTATHIONE; POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL ORGANELLE; CYTOTOXICITY; LIVER MITOCHONDRION; MALE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; RAT; REDUCTION;

BACTERIA (MICROORGANISMS);

EID: 77956937844     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq141     Document Type: Article

References (54)

1. Bertagnolli, B. L., and Hanson, J. B. (1973). Functioning of the adenine nucleotide transporter in the arsenate uncoupling of corn mitochondria. Plant Physiol. 52, 431-435.
2. Bon, S., Godefroy, T., and Grunberg-Manago, M. (1970). Cinétique des réactions catalysées par la polynucléotide phosphorylase de Escherichia coli. Le 2-désoxy-ADP comme substrat et inhibiteur. Eur. J. Biochem. 16, 363-372.
3. Brinkel, J., Khan, M. H., and Kraemer, A. (2009). A systematic review of arsenic exposure and its social and mental health effects with special reference to Bangladesh. Int. J. Environ. Res. Public Health 6, 1609-1619.
4. Chan, T. L., Thomas, B. R., and Wadkins, C. L. (1969). The formation and isolation of an arsenylated component of rat liver mitochondria. J. Biol. Chem. 244, 2883-2890.
5. Chen, H. W., Koehler, C. M., and Teitell, M. A. (2007). Human polynucleotide phosphorylase: location matters. Trends Cell. Biol. 17, 600-608.
6. Chen, H. W., Rainey, R. N., Balatoni, C. E., Dawson, D. W., Troke, J. J., Wasiak, S., Hong, J. S., Mc Bride, H. M., Koehler, C. M., Teitell, M. A., et al. (2006). Mammalian polynucleotide phosphorylase is an intermembrane space RNase that maintains mitochondrial homeostasis. Mol. Cell. Biol. 26, 8475-8487.
7. Chou, J. Y., Singer, M. F., and Mc Phie, P. (1975). Kinetic studies on the phosphorolysis of polynucleotides by polynucleotide phosphorylase. J. Biol. Chem. 250, 508-514.
8. Csanaky, I., and Gregus, Z. (2005). Role of glutathione in reduction of arsenate and of gamma-glutamyltranspeptidase in disposition of arsenite in rats. Toxicology 207, 91-104.
9. Csanaky, I., Németi, B., and Gregus, Z. (2003). Dose-dependent biotransfor-mation of arsenite in rats-not S-adenosylmethionine depletion impairs arsenic methylation at high dose. Toxicology 183, 77-91.
10. Devenish, R. J., Prescott, M., and Rodgers, A. J. (2008). The structure and function of mitochondrial F1FO-ATP synthases. Int. Rev. Cell. Mol. Biol. 267, 1-58.
11. Dilda, P. J., and Hogg, P. J. (2007). Arsenical-based cancer drugs. Cancer Treat. Rev. 33, 542-564.
12. Duée, E. D., and Vignais, P. V. (1969). Kinetics and specificity of the adenine nucleotide translocation in rat liver mitochondria. J. Biol. Chem. 244, 3920-3931.
13. Ghetta, A., Matus-Ortega, M., García-Mena, J., Dehò, G., Tortora, P., and Regonesi, M. E. (2004). Polynucleotide phosphorylase-based photometric assay for inorganic phosphate. Anal. Biochem. 327, 209-214.
14. Godefroy, T., Cohn, M., and Grunberg-Manago, M. (1970). Kinetics of polymerization and phosphorolysis reactions of E. coli polynucleotide phosphorylase. Role of oligonucleotides in polymerization. Eur. J. Biochem. 12, 236-249.
15. Gornall, A. G., Bardawill, C. J., and David, M. M. (1949). Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 177, 751-766.
16. Gregus, Z., Fekete, T., Halászi, É., Gyurasics, Á., and Klaassen, C. D. (1998). Effect of fibrates on glycine conjugation of benzoic acid. Drug Metab. Dispos. 26, 1082-1088.
17. Gregus, Z., Gyurasics, Á., and Csanaky, I. (2000). Biliary and urinary excretion of inorganic arsenic: monomethylarsonous acid as a major biliary metabolite in rats. Toxicol. Sci. 56, 18-25.
18. Gregus, Z., and Németi, B. (2002). Purine nucleoside phosphorylase as a cytosolic arsenate reductase. Toxicol. Sci. 70, 13-19.
19. Gregus, Z., and Németi, B. (2005). The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase works as an arsenate reductase in human red blood cells and rat liver cytosol. Toxicol. Sci. 85, 859-869.
20. Gregus, Z., and Németi, B. (2007). Glutathione-dependent reduction of arsenate by glycogen phosphorylase-responsiveness to endogenous and xenobiotic inhibitors. Toxicol. Sci. 100, 44-53.
21. Gregus, Z., Roos, G., Geerlings, P., and Németi, B. (2009). Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes. II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols. Toxicol. Sci. 110, 282-292.
22. Gresser, M. J. (1981). ADP-arsenate. Formation by submitochondrial particles under phosphorylating conditions. J. Biol. Chem. 256, 5981-5983.
23. Han, D., Canali, R., Rettori, D., and Kaplowitz, N. (2003). Effect of glutathione depletion on sites and topology of superoxide and hydrogen peroxide production in mitochondria. Mol. Pharmacol. 64, 1136-1144.
24. Hughes, M. F. (2006). Biomarkers of exposure: a case study with inorganic arsenic. Environ. Health Perspect. 114, 1790-1796.
25. Hughes, M. F., Kenyon, E. M., and Kitchin, K. T. (2007). Research approaches to address uncertainties in the risk assessment of arsenic in drinking water. Toxicol. Appl. Pharmacol. 222, 399-404.
26. Jocelyn, P. C., and Cronshaw, A. (1985). Properties of mitochondria treated with 1-chloro-2,4-dinitrobenzene. Biochem. Pharmacol. 34, 1588-1590.
27. Jones, D. H., and Boyer, P. D. (1969). The apparent absolute requirement of adenosine diphosphate for the inorganic phosphate-water exchange of oxidative phosphorylation. J. Biol. Chem. 244, 5767-5772.
28. Kitchin, K. T., and Wallace, K. (2008). The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. J. Inorg. Biochem. 102, 532-539.
29. Klingenberg, M. (2008). The ADP and ATP transport in mitochondria and its carrier. Biochim. Biophys. Acta. 1778, 1978-2021.
30. Littauer, U. Z., and Soreq, H. (1982). Polynucleotide phosphorylase. Enzymes 15, 517-553.
31. Mangiullo, R., Gnoni, A., Leone, A., Gnoni, G. V., Papa, S., and Zanotti, F. (2008). Structural and functional characterization of FOF1-ATP synthase on the extracellular surface of rat hepatocytes. Biochim. Biophys. Acta. 1777, 1326-1335.
32. Matus-Ortega, M. E., Regonesi, M. E., Piña-Escobedo, A., Tortora, P., Dehò, G., and García-Mena, J. (2007). The KH and S1 domains of Escherichia coli polynucleotide phosphorylase are necessary for autoregu-lation and growth at low temperature. Biochim. Biophys. Acta. 1769, 194-203.
33. Messens, J., and Silver, S. (2006). Arsenate reduction: thiol cascade chemistry with convergent evolution. J. Mol. Biol. 362, 1-17.
34. Moore, S. A., Moennich, D. M., and Gresser, M. J. (1983). Synthesis and hydrolysis of ADP-arsenate by beef heart submitochondrial particles. J. Biol. Chem. 258, 6266-6271.
35. Németi, B., Csanaky, I., and Gregus, Z. (2003). Arsenate reduction in human erythrocytes and rats-testing the role of purine nucleoside phosphorylase. Toxicol. Sci. 74, 22-31.
36. Németi, B., and Gregus, Z. (2002). Mitochondria work as reactors in reducing arsenate to arsenite. Toxicol. Appl. Pharmacol. 182, 208-218.
37. Németi, B., and Gregus, Z. (2004). Glutathione-dependent reduction of arsenate in human erythrocytes-a process independent of purine nucleoside phosphorylase. Toxicol. Sci. 82, 419-428.
38. Németi, B., and Gregus, Z. (2007). Glutathione-dependent reduction of arsenate by glycogen phosphorylase-a reaction coupled to glycogenolysis. Toxicol. Sci. 100, 36-43.
39. Németi, B., and Gregus, Z. (2009a). Glutathione-supported arsenate reduction coupled to arsenolysis catalyzed by ornithine carbamoyl transferase. Toxicol. Appl. Pharmacol. 239, 154-161.
40. Németi, B., and Gregus, Z. (2009b). Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes. I. The role of arsenolysis. Toxicol. Sci. 110, 270-281.
41. Páez-Espino, D., Tamames, J., de Lorenzo, V., and Cánovas, D. (2009). Microbial responses to environmental arsenic. Biometals 22, 117-130.
42. Piwowarski, J., Grzechnik, P., Dziembowski, A., Dmochowska, A., Minczuk, M., and Stepien, P. P. (2003). Human polynucleotide phos-phorylase, hPNPase, is localized in mitochondria. J. Mol. Biol. 329, 853-857.
43. Platanias, L. C. (2009). Biological responses to arsenic compounds. J. Biol. Chem. 284, 18583-18587.
44. Radabaugh, T. R., Sampayo-Reyes, A., Zakharyan, R. A., and Aposhian, H. V. (2002). Arsenate reductase II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Chem. Res. Toxicol. 15, 692-698.
45. Rainey, R. N., Glavin, J. D., Chen, H. W., French, S. W., Teitell, M. A., and Koehler, C. M. (2006). A new function in translocation for the mitochondrial i-AAA protease Yme1: import of polynucleotide phosphorylase into the intermembrane space. Mol. Cell. Biol. 26, 8488-8497.
46. Rosen, B. P. (2002). Biochemistry of arsenic detoxification. FEBS Lett. 529, 86-92.
47. Sarkar, D., and Fisher, P. B. (2006). Polynucleotide phosphorylase: an evolutionary conserved gene with an expanding repertoire of functions. Pharmacol. Ther. 112, 243-263.
48. See, Y. P., and Fitt, P. S. (1972a). Partial purification and properties of rat liver mitochondrial polynucleotide phosphorylase. Biochem. J. 130, 343-353.
49. See, Y. P., and Fitt, P. S. (1972b). A study of the localization of polynucleotide phosphorylase within rat liver cells and of its distribution among rat tissues and diverse animal species. Biochem. J. 130, 355-362.
50. Stýblo, M., Drobná, Z., Jaspers, I., Lin, S., and Thomas, D. J. (2002). The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ. Health Perspect. 110, 767-771.
51. Thomas, D. J. (2007). Molecular processes in cellular arsenic metabolism. Toxicol. Appl. Pharmacol. 222, 365-373.
52. Tietze, F. (1969). Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal. Biochem. 27, 502-522.
53. Tseng, C. H. (2007). Metabolism of inorganic arsenic and non-cancerous health hazards associated with chronic exposure in humans. J. Environ. Biol. 28, 349-357.
54. Villa-Bellosta, R., and Sorribas, V. (2008). Role of rat sodium/phosphate cotransporters in the cell membrane transport of arsenate. Toxicol. Appl. Pharmacol. 232, 125-134.